MKS Instruments vs Revolution Medicines Inc. Common Stock — how do they compare? MKS Instruments trades at $265.61 (market cap $17.61B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.3× MKS Instruments's market cap, and MKS Instruments pays a 0.38% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MKS Instruments for 7 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| MKSI | RVMD | |
|---|---|---|
Market Cap | $17.61B | $40.32B |
Volume | 1,275,355 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $444.80 | $221.15 |
52-Week Low | $121.26 | $47.50 |
Typical Hold Time | 7 Days | 0 Days |
Enterprise Value | $21.18B | $37.02B |
Dividend Yield | 0.38% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →